IRIDEX CORP Provision for Other Credit Losses
IRIDEX CORP (IRIX) reported Provision for Other Credit Losses of $0 for the 12-month period ending 2023-12-30, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForOtherCreditLosses · last filed 2024-03-29
- IRIDEX CORP provision for other credit losses for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IRIDEX CORP provision for other credit losses for fiscal 2022 was $187.00K.
| Period end | Provision for Other Credit Losses 12 month |
|---|---|
| 2023-12-30 | $0.00 10-K · filed 2024-03-29 |
| 2022-12-31 | $187.00K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |